Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Argus Health
Queensland Health

Generated: October 24, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,096,885

« Back to Dashboard

Summary for Patent: 5,096,885

Title: Human growth hormone formulation
Abstract:A stable pharmaceutically acceptable formulation containing human growth hormone, glycine, mannitol, a buffer, and optionally, a non-ionic surfactant is disclosed. The formulation contains human growth-hormone: glycine in 1:50-200 molar ratios. Also disclosed are associated means and methods for preparing and using such formulations.
Inventor(s): Pearlman; Rodney (El Granada, CA), Oeswein; James Q. (Montara, CA)
Assignee: Genentech, Inc. (South San Francisco, CA)
Application Number:07/182,262
Patent Claim Types:
see list of patent claims
Formulation; Compound; Use; Dosage form; Device;

No matches for this query

International Patent Family for Patent: 5,096,885

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria197405► Subscribe
Austria359824► Subscribe
Australia627174► Subscribe
Australia4792793► Subscribe
Australia686567► Subscribe
Australia3368789► Subscribe
Canada1329543► Subscribe
Canada2139358► Subscribe
Canada2337745► Subscribe
Canada2489978► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Daiichi Sankyo
Cantor Fitzgerald
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus